178 related articles for article (PubMed ID: 8373133)
1. Purine degradative enzymes and terminal transferase in acute myelogenous leukemia: clinical relevance.
Patmasiriwat P; Anukarahanonta T; Chinprasertsuk S
Ann Clin Lab Sci; 1993; 23(4):281-9. PubMed ID: 8373133
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Babusíková O
Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
[TBL] [Abstract][Full Text] [Related]
4. Phorbol esters induce changes in adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyl transferase messenger RNA levels in human leukemic cell lines.
Madrid-Marina V; Martinez-Valdez H; Cohen A
Cancer Res; 1990 May; 50(10):2891-4. PubMed ID: 2110502
[TBL] [Abstract][Full Text] [Related]
5. Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
Leukemia; 1992 May; 6(5):375-80. PubMed ID: 1593902
[TBL] [Abstract][Full Text] [Related]
6. [Adenosine deaminase, purine nucleoside phosphorylase and ecto-5'-nucleotidase--markers of acute leukemia variants].
Filanovskaia LI; Togo AV; Tsveĭbakh AS; Blinov MN; Alekseev NA
Vopr Med Khim; 1987; 33(4):16-21. PubMed ID: 2821693
[TBL] [Abstract][Full Text] [Related]
7. Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes.
Ma DD; Sylwestrowicz TA; Granger S; Massaia M; Franks R; Janossy G; Hoffbrand AV
J Immunol; 1982 Oct; 129(4):1430-5. PubMed ID: 6286766
[TBL] [Abstract][Full Text] [Related]
8. [Interrelation of degradation processes of purine nucleotides and their biosynthetic transformation in the blood cells of patients with acute leukemia].
Filanovskaia LI; Togo AV; Blinov MN
Eksp Onkol; 1989; 11(4):59-63. PubMed ID: 2569387
[TBL] [Abstract][Full Text] [Related]
9. [The clinical diagnostic value of a study of the activity of enzymes of the guanyl branch of purine metabolism in patients with ankylosing spondyloarthritis].
Zborovskiĭ AB; Mozgovaia EE; Martem'ianov VF; Sliusar' OP; Stazharov MIu; Bedina SA
Ter Arkh; 2010; 82(4):48-52. PubMed ID: 20481216
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype.
Brusamolino E; Isernia P; Lazzarino M; Scovassi I; Bertazzoni U; Bernasconi C
J Clin Oncol; 1984 Aug; 2(8):871-80. PubMed ID: 6589363
[TBL] [Abstract][Full Text] [Related]
11. [Immune insufficiency in enzyme defects of purine metabolism].
Müller G
Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
[TBL] [Abstract][Full Text] [Related]
12. Adenosine deaminase, nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase activity in normal lymphocyte subpopulations.
Davis S; Rambotti P
Anticancer Res; 1982; 2(3):125-8. PubMed ID: 6812486
[TBL] [Abstract][Full Text] [Related]
13. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
Mesárosová A; Hrivnáková A; Babusíková O
Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of terminal transferase and adenosine deaminase in leukemia.
Brusamolino E; Bertazzoni U; Isernia P; Ginelli E; Scovassi AI; Zurlo MG; Plevani P; Sacchi N; Bernasconi C
Adv Exp Med Biol; 1982; 145():279-303. PubMed ID: 7051780
[TBL] [Abstract][Full Text] [Related]
15. [Degradation of purines in leukocytes in acute nonlymphoblastic leukemias].
Filanovskaia LI; Blinov MN; Togo AV; Klubovskaia NI; Burmistrova EV
Vopr Med Khim; 1988; 34(6):71-6. PubMed ID: 2853490
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
Bertazzoni U; Brusamolino E; Isernia P; Scovassi AI; Torsello S; Lazzarino M; Bernasconi C
Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase and terminal deoxynucleotidyl transferase: biochemical markers in the management of chronic myelogenous leukemia.
Grever MR; Coleman MS; Balcerzak SP
Cancer Res; 1983 Mar; 43(3):1442-5. PubMed ID: 6572097
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma.
Sanfilippo O; Camici M; Tozzi MG; Turriani M; Faranda A; Ipata PL; Silvestrini R
Cancer Biochem Biophys; 1994 Apr; 14(1):57-66. PubMed ID: 7796389
[TBL] [Abstract][Full Text] [Related]
19. [Adenosine deaminase activity in leukemia patients].
Müller G; Krug K; Richter V; Krüger W; Rassoul F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):763-8. PubMed ID: 6176499
[TBL] [Abstract][Full Text] [Related]
20. Activity of adenosine deaminase and of purine nucleoside phosphorylase in peripheral lymphocytes from patients with acquired immunological disorders.
Sidi Y; Boer P; Pick I; Pinkhas J; Sperling O
Biomedicine; 1980 Apr; 33(2):39-41. PubMed ID: 6773594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
